1. Home
  2. HCTI vs LABT Comparison

HCTI vs LABT Comparison

Compare HCTI & LABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$1.62

Market Cap

3.9M

Sector

Technology

ML Signal

HOLD

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.52

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HCTI
LABT
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9M
4.6M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HCTI
LABT
Price
$1.62
$2.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
79.1K
2.1M
Earning Date
04-16-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,891,000.00
N/A
Revenue This Year
$79.33
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.77
N/A
52 Week Low
$0.14
$1.66
52 Week High
$20.42
$6.85

Technical Indicators

Market Signals
Indicator
HCTI
LABT
Relative Strength Index (RSI) 37.41 46.44
Support Level $0.14 $1.88
Resistance Level $2.64 $2.92
Average True Range (ATR) 0.12 0.65
MACD 0.00 0.08
Stochastic Oscillator 0.00 20.81

Price Performance

Historical Comparison
HCTI
LABT

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

Share on Social Networks: